Monrovia, Ca., USA — STAAR Surgical Company, a developer of implantable lenses and delivery systems for the eye, announced the appointment of Kathryn Tunstall to its board of directors.[break]
Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a developer, maker, and marketer of medical devices for women. In 2013 Conceptus was acquired by Bayer AG.
In addition to her position as Chairman of Conceptus, Ms. Tunstall served as the company's first President and Chief Executive Officer from 1993 - January 31, 2014, Monrovia, Ca., USA — STAAR Surgical Company, a developer of implantable lenses and delivery systems for the eye, announced the appointment of Kathryn Tunstall to its board of directors.
Article continues below
]
Ms. Tunstall brings nearly 40 years of leadership experience in the pharmaceutical and medical device industry, most recently serving for the past 13 years as Chairman of Conceptus, Inc., a developer, maker, and marketer of medical devices for women. In 2013 Conceptus was acquired by Bayer AG.
In addition to her position as Chairman of Conceptus, Ms. Tunstall served as the company's first President and Chief Executive Officer from 1993-2000. During her tenure with Conceptus, the company achieved a number of major milestones, including an expedited FDA approval of the first non-surgical female permanent contraceptive device and twice being recognized as one of Silicon Valley's fastest growing companies.
Prior to joining Conceptus in 2000, Ms. Tunstall served for seven years in executive leadership roles with Baxter International, most recently as President of the Company's Edwards Less Invasive Surgery Division. She also spent more than 12 years in various marketing, finance and operational roles with divisions of American Hospital Supply, including McGaw Laboratories, a division that manufactured and sold medical equipment and disposable supplies.
Ms. Tunstall's prior corporate governance experience includes both private and public boards. She currently serves on the board of Auxogyn, Inc., a venture-backed medical technology company focused on women's reproductive health.
Ms. Tunstall previously served as chairman of two private development-stage companies she co-founded; Fair Advantage Inc., a development-stage educational company and HopeLink Corporation, an information solutions company for improving new product development efforts in the bio-pharmaceutical industry by locating and enrolling patients in treatment trials.
Ms. Tunstall also served as a director, chair of the compensation committee and the audit committee for Caliper Life Sciences, a publicly-traded provider of leading-edge technologies enabling researchers to create medicines and diagnostic tests more quickly and efficiently. Caliper was acquired by PerkinElmer in 2011.
Ms. Tunstall received her B.A. in Economics from the University of California- Santa Barbara.
STAAR also announced that Don M. Bailey, the Company's Chairman of the Board since 2005, is turning over the chairman's role to Mark Logan in a planned transition.
Mr. Logan was appointed to the STAAR board in 2010 and serves as the Chair of the Compensation Committee. He has 35 years of executive level experience in the health care products industry and is currently co-founder and President and CEO of TearSolutions, L.L.C. Mr. Logan also serves as a non-executive Director at VIVUS, Inc., as a member of the board at the University of Virginia Heart & Vascular Center, as a director of Public Policy Virginia, Inc..
Mr. Logan served as Chairman and Chief Executive Officer of VISX, Inc. from 1994 to 2001. VISX was acquired by Advanced Medical Optics, and subsequently by Abbott Laboratories in 2009.
Prior to joining VISX, he was Chairman and CEO of Insmed Pharmaceuticals, Inc., and served as a principal at McManus Associates, a health care research and management firm, whose clients included Merck, Bristol Myers Squibb and American Diabetes Association. Mr. Logan was also Executive Vice President and Chief Operating Officer and board member at Bausch & Lomb. ■